Wellington Management Group LLP Has $22.56 Million Holdings in ICU Medical, Inc. (NASDAQ:ICUI)

Wellington Management Group LLP decreased its holdings in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 84.5% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 145,374 shares of the medical instruments supplier's stock after selling 792,122 shares during the quarter. Wellington Management Group LLP owned 0.59% of ICU Medical worth $22,558,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently bought and sold shares of the company. Harvest Fund Management Co. Ltd purchased a new position in ICU Medical during the 4th quarter valued at about $33,000. Quarry LP raised its holdings in ICU Medical by 764.3% during the fourth quarter. Quarry LP now owns 242 shares of the medical instruments supplier's stock valued at $38,000 after buying an additional 214 shares in the last quarter. Murphy & Mullick Capital Management Corp acquired a new stake in shares of ICU Medical in the fourth quarter worth about $52,000. Venturi Wealth Management LLC boosted its stake in shares of ICU Medical by 64.0% during the 4th quarter. Venturi Wealth Management LLC now owns 528 shares of the medical instruments supplier's stock worth $82,000 after acquiring an additional 206 shares in the last quarter. Finally, Russell Investments Group Ltd. increased its holdings in shares of ICU Medical by 88.8% during the 4th quarter. Russell Investments Group Ltd. now owns 638 shares of the medical instruments supplier's stock valued at $99,000 after acquiring an additional 300 shares during the last quarter. 96.10% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities research analysts have issued reports on ICUI shares. Wall Street Zen raised ICU Medical from a "hold" rating to a "buy" rating in a research report on Sunday, May 18th. Raymond James dropped their target price on shares of ICU Medical from $197.00 to $187.00 and set a "strong-buy" rating on the stock in a report on Friday, May 9th. KeyCorp cut their target price on shares of ICU Medical from $209.00 to $191.00 and set an "overweight" rating for the company in a research report on Monday, April 21st. Finally, Needham & Company LLC restated a "hold" rating on shares of ICU Medical in a report on Tuesday, April 8th. One equities research analyst has rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, ICU Medical currently has a consensus rating of "Buy" and an average price target of $192.67.

Insider Buying and Selling

In other news, insider Ben Sousa sold 2,000 shares of the stock in a transaction on Thursday, May 15th. The shares were sold at an average price of $137.36, for a total value of $274,720.00. Following the completion of the transaction, the insider now owns 479 shares in the company, valued at approximately $65,795.44. This represents a 80.68% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, COO Christian B. Voigtlander sold 4,985 shares of ICU Medical stock in a transaction that occurred on Wednesday, May 28th. The shares were sold at an average price of $128.50, for a total value of $640,572.50. Following the sale, the chief operating officer now directly owns 6,088 shares in the company, valued at $782,308. The trade was a 45.02% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 36,097 shares of company stock valued at $4,860,156 over the last three months. 1.50% of the stock is owned by corporate insiders.

ICU Medical Stock Performance

Shares of ICU Medical stock traded up $0.82 during midday trading on Wednesday, hitting $131.36. The company had a trading volume of 262,024 shares, compared to its average volume of 277,871. ICU Medical, Inc. has a 1-year low of $105.30 and a 1-year high of $196.26. The business's 50 day simple moving average is $137.06 and its two-hundred day simple moving average is $150.27. The stock has a market cap of $3.23 billion, a PE ratio of -28.74 and a beta of 0.87. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.29 and a quick ratio of 1.03.

ICU Medical (NASDAQ:ICUI - Get Free Report) last posted its quarterly earnings results on Thursday, May 8th. The medical instruments supplier reported $1.72 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.23 by $0.49. ICU Medical had a negative net margin of 4.74% and a positive return on equity of 5.05%. The company had revenue of $599.49 million for the quarter, compared to analyst estimates of $574.15 million. During the same period last year, the business posted $0.96 EPS. The business's quarterly revenue was up 6.7% on a year-over-year basis. As a group, equities analysts predict that ICU Medical, Inc. will post 4.11 EPS for the current fiscal year.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.